Our Blog

Celebrating the Success of Clinical Trial

International Clinical Trials Day 20th May 2023 “Taking part in clinical research gives us hope – the breakthrough may be just around the corner – and we […]

Re:Cognition Health becomes first network of clinical trial sites to have achieved GCSA Accredited status

London and Maidenhead, United Kingdom, 21 February 2023 – Re:Cognition Health’s commercial clinical research operational processes have undergone a rigorous evidence-based assessment to achieve all seven GCSA […]

Historical moment for Alzheimer’s treatment Re:Cognition Health proud to deliver lecanemab clinical trial

Re:Cognition Health’s Brain and Mind Experts are excited and proud to be delivering “Clarity“ the global clinical trial for Lecanemab, as the result of the trial is […]

What a world-leading Neuroradiologist wants you to know about CTE

With Chronic Traumatic Encephalopathy (CTE) diagnosis rates increasing rapidly and as we become more aware of the condition, particularly being brought to the forefront with international rugby […]

How are smartphones affecting children?

Whilst smartphones are part of everyday life for the majority of adults, more and more teenagers are becoming reliant upon them for social connections, directions, games and […]

Re:Cognition Health is absolutely thrilled to be shortlisted as a finalist in the Personal Injury Awards 2022 for Medicolegal Provider of the Year.

Under the leadership of multi-award-winning CEO and Consultant Neuroradiologist Dr Emer MacSweeeney and Director of Neurological Services Dr Steve Allder, our medicolegal team provide high-quality expertise in […]

LaingBuisson Awards 2022

Re:Cognition Health is absolutely delighted to announce that our team has been shortlisted in three categories in the LaingBuisson 2022 Awards which set the standards of excellence […]

Is your lifestyle increasing your risk of dementia?

 Dr Emer MacSweeney, Consultant Neuroradiologist and CEO at Re:Cognition Health spoke with Health Tech World about how our  lifestyle choices may be increasing our risk of dementia. Recent research […]

Amyloid and Alzheimer’s

Amyloid and Alzheimer’s By R. Scott Turner, PhD, MD   Recent reports of fraud in Alzheimer’s disease (AD) research have raised major concerns. Some of the figures […]

Emer Fox5 News

Dr Emer MacSweeney, CEO, Medical Director and Consultant Neuroradiologist at Re:Cognition Health appeared on Fox5 News, USA,  talking about the exciting and important opportunity provided through clinical […]